About
Cancer Immunotherapies, Oncolytic Viruses
Areas of Focus
Categories
Virus Technology
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
380
By Phase
PHASE2: 2PHASE1/PHASE2: 3
By Status
COMPLETED: 3TERMINATED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06637527Lead Sponsor
The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain
PHASE2Terminated
18 participants
Started: Oct 15, 2024 · Completed: Jul 1, 2025
NCT05759208Lead Sponsor
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
PHASE2Completed
240 participants
Started: Apr 28, 2023 · Completed: Dec 15, 2023
NCT04123470Lead Sponsor
A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma
PHASE1/PHASE2Completed
24 participants
Started: Jan 28, 2020 · Completed: Jul 30, 2023
NCT03225989Lead Sponsor
Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer
PHASE1/PHASE2Completed
47 participants
Started: Mar 1, 2018 · Completed: Aug 22, 2023
NCT02705196Lead Sponsor
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
PHASE1/PHASE2Active, not recruiting
51 participants
Started: Nov 30, 2016 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Uppsala, Sweden
Map
Loading map...